Ajovy is one of the CGRP inhibitors used for migraine prevention. Approved for ages 6 and up, it's noted for its safety, tolerability, and benefits seen within the first month.
What Is Ajovy and Why Does It Matter? Ajovy (fremanezumab) is a medicine approved to help prevent migraines. It is a lab-made monoclonal antibody that blocks a protein called calcitonin gene-related ...
Teva Pharmaceutical Industries Ltd. announced the final analysis of the PEARL Phase 4 study at the European Academy of Neurology Congress 2025, confirming that AJOVY (fremanezumab) is effective in ...